Elevated Plasma Renin Activity Predicts Adverse Outcome in Chronic Heart Failure, Independently of Pharmacologic Therapy: Data From the Valsartan Heart Failure Trial (Val-HeFT)

✍ Scribed by Serge Masson; Scott Solomon; Laura Angelici; Roberto Latini; Inder S. Anand; Margaret Prescott; Aldo P. Maggioni; Gianni Tognoni; Jay N. Cohn

• Book ID: 116340402
• Publisher: Elsevier Science
• Year: 2010
• Tongue: English
• Weight: 350 KB
• Volume: 16
• Category: Article
• ISSN: 1532-8414
• DOI: 10.1016/j.cardfail.2010.06.417